Mice deficient in RIPK2 exhibited a reduced inflammatory response and neuronal apoptosis, with a smaller infarct volume and improved neurological deficits score, while neuron-specific RIPK2 overexpressing transgenic mice displayed worse stroke outcomes than wild-type (WT) controls [11]. This evidence concerns the gene RIPK2 and stroke disorder.